Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company that develops, manufactures, and commercializes immunobiotics, consisting of vaccines and therapeutics that assist the body's immune system to prevent or treat disease. The company's biodefense business focuses on immunobiotics for use against biological agents that are potential weapons of bioterrorism and biowarfare. Its marketed product, BioThrax� (Anthrax Vaccine Adsorbed), is the only vaccine approved by the FDA for the prevention of anthrax infection. The company's commercial business focuses on immunobiotics for use against infectious diseases and other medical conditions that have resulted in significant unmet or undeserved public health needs.